Biotech 2050 Podcast - Revolutionizing the drug discovery marketplace

Share on twitter
Share on linkedin

Kevin Lustig, Founder and CEO of joins the podcast.

Kevin is a scientist-entrepreneur with 30 years of research experience in academia and pharma.


Kevin Lustig made the transition from academia into biotech just before its boom. He talks through the journey of, from its founding in 2007 up to now. empowers scientists and researchers to reach out to labratories around the world so they can connect to find faster, cheaper yet better ways to finding cures for human diseases.

The entrepreneur admits the company is bold and bold, with a mission to cure all human disease by 2050!


Check out the podcast here.

(0) comments

You may also like

Subscribe to ProcureTech Bulletin

ProcureTech Bulletin

Get our latest insights, ideas and news straight into your inbox

What is your main digital procurement solutions role?